Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study.
Lombardi D, Scalone S, Crivellari D, Magri MD, La Mura N, Miolo G, Murrone A, Perin T, Coran F, Candiani E, Massarut S, Veronesi A.
Lombardi D, et al. Among authors: la mura n.
Tumori. 2010 Mar-Apr;96(2):229-33. doi: 10.1177/030089161009600207.
Tumori. 2010.
PMID: 20572578
Clinical Trial.